Prostate cancer and men's condition

Men with prostate cancer who were previously infected with the sexually transmitted germ Trichomonas vaginal are more likely to have an combative configuration of the cancer compared with men who never had the STD. The germ, a type of parasite, can infect the prostate and may cause redness that spurs the cultivation of prostate cancer later in life.In the study, Mucci and colleagues compared 673 prostate cancer patients to 673 men without prostate cancer, and tested their blood for signs of a past infection with trichomonas. All of the men were enrolled in the Physician’s Health Study, according to the report published this week in the Magazine of the National Cancer Institute.The researchers establish that roughly 1 in 5 men had been infected with trichomonas at some point in his life.  Men infected with trichomonas were no more likely than STD-free men to bring out prostate cancer in general. But those with a past trichomonas infection were two to three times more likely to advance an combative and potentially life-threatening configuration of prostate cancer. Trichomonas affects 174 million people around the world each year and, at any given period, about 3% of younger men are infected with trichomonas; it is most common in men ages 25 to 39. However, trichomonas is an STD that’s probably on more women’s radars because women are more likely than men to get symptoms such as release and itching. Only 1 out of 4 men with trichomonas develops symptoms, and, with period, the infection often goes away on its own.

Risks of Testosterone Treatment

Testosterone replacement so far seems to be usually unharmed. Experts accentuate that the benefits and risks of extensive-term testosterone remedy are unrecognized, because great clinical trials haven't yet been done.

There are a few condition conditions that experts believe testosterone treatment can increase:

    Benignant prostatic hypertrophy (BPH): The prostate grows as a matter of course under the stimulation of testosterone. For many men, their prostates increase larger as they age, squeezing the tube carrying urine (urethra). The outcome is strain urinating. This qualification, kindly prostatic hypertrophy, can be made worse by testosterone remedy.
    Prostate cancer: Testosterone can activate prostate cancer to flourish. Most experts advise screening for prostate cancer before starting testosterone replacement. Men with prostate cancer or upraised prostate definite antigen (PSA) should probably keep away from testosterone treatment.
    Rest apnea: This requirement can be worsened by testosterone replacement. It may be hard for a man to uncover this himself, but his sleeping partner can often tell. A repose read (polysomnography) may be needed to build the diagnosis.
    Erythrocytes (lofty blood counts): Testosterone supplements increase the red blood cell count up -- possibly making blood "thicker" and perhaps more prone to clotting. Men with the highest blood chamber counts may be at greater danger for condition problems with testosterone treatment. Elementary blood tests can line your red blood room count.
    Congestive pump failing: Men with severe congestive ticker failing should usually not take testosterone replacement, as it can worsen the stipulation.It will be years before great clinical trials carry any answers on the extensive-term benefits and risks of testosterone therapy. As with any medication, the determination on whether the possible benefits overcome any risks is up to you and your doctor.